African American Cancer Survivors' Perspectives on Cancer Clinical Trial Participation in a Safety-Net Hospital: Considering the Role of the Social Determinants of Health
- PMID: 33728872
- PMCID: PMC8443686
- DOI: 10.1007/s13187-021-01994-4
African American Cancer Survivors' Perspectives on Cancer Clinical Trial Participation in a Safety-Net Hospital: Considering the Role of the Social Determinants of Health
Abstract
Although there has been an increase focus on recruitment of minority populations at safety-net hospitals into cancer clinical trials, there is still a paucity of research exploring minority participation in cancer clinical trials at safety-net settings. The study utilized a multi-level, qualitative approach to assess the clinical and non-clinical facilitators and barriers to African American participation in cancer clinical trials at a safety-net hospital. From June 2018 to July 2019, cancer survivors (n = 25) were recruited from a cancer center at a safety-net hospital in the southeastern USA and participated in a 60-min focus group. Data was coded and analyzed to identify the most prominent themes. Most participants were female (78%), with a mean age of 56 years. The majority were diagnosed with breast cancer (68%) and disabled or unemployed (55%). Major themes identified were (1) lack of understanding of cancer clinical trials, (2) perceptions and fears of cancer clinical trials, and (3) preferred role and characteristics of patient navigator. The barriers and facilitators to enrollment in cancer clinical trials were more pronounced in the safety-net setting, given the overdue burden of social determinants of health. Study findings yield important insights and essential practices for recruiting and engaging underrepresented Black cancer patients into cancer clinical trials, specifically for safety-net settings. Including patient navigators may help traverse potential barriers to cancer clinical trial participation and will allow for the attention to social determinants of health, and ultimately increase the number of African Americans participating in cancer clinical trials.
Keywords: African Americans; Cancer clinical trials; Health disparities; Safety-net hospitals; Social determinants of health.
© 2021. American Association for Cancer Education.
References
-
- Chen MS Jr, Lara PN, Dang JHT, Paterniti DA, Kelly K (2014) Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials. Cancer 120: 1091–1096 - PMC - PubMed
-
- Duma N, Aguilera JV, Paludo J, Haddox CL, Velez MG, Wang Y, Leventakos K, Hubbard JM, Mansfield AS, Go RS (2018) Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract 14(1):e1–e10 - PubMed
-
- Ford JG, Howerton MW, Lai GY, Gary TL, Bolen S, Chris Gibbons M, Tilburt J, Baffi C, Tanpitukpongse TP, Wilson RF (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical